Long-term Outcomes in Terms of Disability and Quality of Life for Patients Undergoing Posterior Cranial Fossa Craniectomy in the Context of Compressive Cerebellar Hematoma (CHANCE)

Grenoble Alpes University Hospital Center (CHU)

Status: Completed

Conditions: Craniectomy; Quality of Life; Handicap Mental; Cerebellar Haematoma; Handicaps Physical

Treatments: Behavioral: SF36 questionary

Study type: Observational

Funder types: Other

Identifiers

NCT04672785

38RC20.355

2020-A02717-32 (Registry Identifier)

Details and patient eligibility

About

Posterior cranial fossa craniectomy has been shown to improve patient survival. The level of autonomy, disability and quality of life of survivors has been little studied and still underresearched,.

In this context, an assessment of the level of disability and of the quality of life after performing a posterior craniectomy seems relevant.

Full description

Investigators are carrying out a retrospective observational, single-center study, in three intensive care units in the Grenoble Hospital Center. Every patients who underwent a posterior fossa craniectomy for a cerebellar hematoma at Grenoble University Hospital between 01/01/2010 and 01/01/2020 were enrolled in this study. The main objective is to assess the level of disability and the quality of life of patients who have had a posterior cranial fossa craniectomy. The primary outcome is the mRS(Modified Rankin score) measured at least one year following the ICU discharge. Secondary outcomes are the mRS(Modified Rankin Score) measured at discharge from the rehabilitation department, the GOS (Glasgow Outcome score) measured at least one year following the discharge from intensive care, and the SF36 (The Short Form 36)from the medical outcome study, score assessing the quality of life, collected via phone call.

Enrollment: 26 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient who underwent a posterior cranial fossa craniectomy in the context of an acute cerebellar hematoma between January 01, 2012 to January 01, 2020.
• Adult man or woman
• Hospitalized in intensive care
• No opposition from the patient or a loved one to a telephone contact to determine the SF36 (The Short Form) quality of life scale, from the medical outcome study.

Exclusion criteria

• Subject under guardianship or subject deprived of liberty
• Early limitation of active therapy before 48 hours.

Trial design

26 participants in 1 patient group

Patients who underwent a posterior fossa craniectomy for a cerebellar hematoma

Treatment:

Behavioral: SF36 questionary